30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: RTI Surgical

4Q14 revenue: $55.9MM, +22%

2014 revenue: $203.3MM, +43%

Spine $82.6MM, +44%

Sports Medicine $46.7MM, +10%

Bone Graft Substitutes/General Orthopaedic $36.7MM, +32%

Fixation $37.1MM, +156%

Highlights pertain to 2014.

  • Announced 1st human implantation of map3 Cellular Allogeneic Bone Graft Strips
  • 2015 growth initiatives include a focus on nanOss 3D Advanced Bone Graft Substitute, map3, capturing share in spine hardware
  • Expecting SportsMed growth rate in mid- to high-single-digits for 2015